Medication info

Cavadil 16 mg Tablet (Candesartan Cilexetil)

Prescription medicationTabletOralExpired
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Samah Pharmaceutical Co., Ltd.
Appearance
Pink round tablet
Packaging
30 tablets, 100 tablets (bottle)
Approval status
Expired

MFDS item code 201005078 · Approved 2010.08.19

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take this medicine at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild-to-moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into consideration, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension 6) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure 3) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Ingredients

Manufacturer
Samah Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • left ventricular dysfunction
  • heart failure patients
View approved original text

This medication is used to treat essential hypertension. It is also effectively used in heart failure patients with reduced left ventricular ejection fraction who require additional treatment to ACE inhibitors or who have poor tolerance. Therefore, it helps improve hypertension and certain heart failure conditions.

How to take

Adult dose

Take this medicine at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild-to-moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into consideration, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension 6) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure 3) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This drug should not be administered to women who are pregnant or potentially pregnant, nursing mothers, patients with severe liver impairment, patients with hereditary angioedema, and patients with certain genetic lactose metabolism disorders. Elderly patients, those with hyperkalemia, patients with poor liver function, patients with valvular heart disease, and patients with poor kidney function should exercise special caution when using this medication. During treatment with this drug, side effects such as dizziness, back pain, and respiratory infections may occur, and in heart failure patients, low blood pressure, hyperkalemia, and renal impairment may occur, necessitating regular checks. If blood pressure drops excessively or severe side effects occur, medical consultation should be sought immediately, and patients undergoing dialysis or those taking diuretics must use this medication with extra caution. This drug may increase the blood pressure-lowering effect if taken with other blood pressure medications, and caution is needed when taken in conjunction with lithium as lithium levels may increase. Additionally, when combined with non-steroidal anti-inflammatory drugs (NSAIDs), the risk of renal function deterioration may increase, so renal function should be monitored periodically when used together. Pregnant or nursing women are advised not to use this drug; if unavoidable, breastfeeding should be discontinued. The safety and efficacy in pediatric and adolescent patients under 18 years of age have not been established, so its use is not recommended. Overdosage may result in symptoms such as hypotension, dizziness, and tachycardia, and appropriate emergency treatment should be received if necessary. This drug should be kept out of the reach of children, and it is safest not to transfer it to other containers.

Side effects

  • dizziness
  • low back pain
  • respiratory infection
  • upper respiratory infection
  • pharyngitis
  • rhinitis
  • fatigue
  • peripheral edema
  • chest pain
  • headache
Show 79 more
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • joint pain
  • proteinuria
  • weakness
  • fever
  • sensory disturbances
  • dyspepsia
  • gastritis
  • tachycardia
  • palpitation
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • kidney function impairment
  • elevated creatinine
  • increased urea
  • elevated ALT
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • dizziness
  • headache
  • nausea
  • diarrhea
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • increased γ-GTP
  • jaundice
  • rash
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • joint pain
  • myalgia
  • low back pain
  • kidney function impairment
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • syncope
  • flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbance
  • reduced libido
  • forgetfulness
  • loss of appetite
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to keep the storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Pink round tablet

Package unit

30 tablets, 100 tablets (bottle)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.